Overview:

CD147 is a highly glycosylated transmembrane protein that acts as the main upstream stimulator of matrix metalloproteinases (MMPs) (1). It has been reported to bind viral Spike protein of SARS-Co-2, thereby playing a functional role in mediating the viral invasion of the host cell. It also acts as an RBC receptor for Plasmodium falciparum, a Malarial protozoan (2). In addition, expression level of CD147 is increased in tumor tissue, inflammation, and pathogenically infected cells. Therefore, CD147 receptor blocking drugs may provide novel therapeutic strategies against viral invasions, such as 2019-nCoV (3).

Gene Aliases:

Basigin, EMMPRIN

Genebank Number:

NM_198589

Formulation:

Recombinant protein stored in 50mM sodium phosphate, pH 7.5, 300mM NaCl, 150mM imidazole.

References:

1. Kong LM, et al: A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. Cancer Research. 2014, 74(14):3764-78.

2. Wang K, et al SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. 2020 doi: https://doi.org/10.1101/2020.03.14.988345

3. Ulrich H, et al: CD147 as a target for COVID-19 treatment: Suggested effects of azithromycin and stem cell engagement.